168 related articles for article (PubMed ID: 15039213)
41. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
42. Activating c-kit gene mutations in human germ cell tumors.
Tian Q; Frierson HF; Krystal GW; Moskaluk CA
Am J Pathol; 1999 Jun; 154(6):1643-7. PubMed ID: 10362788
[TBL] [Abstract][Full Text] [Related]
43. MiniSOX9, a dominant-negative variant in colon cancer cells.
Abdel-Samad R; Zalzali H; Rammah C; Giraud J; Naudin C; Dupasquier S; Poulat F; Boizet-Bonhoure B; Lumbroso S; Mouzat K; Bonnans C; Pignodel C; Raynaud P; Fort P; Quittau-Prévostel C; Blache P
Oncogene; 2011 Jun; 30(22):2493-503. PubMed ID: 21297661
[TBL] [Abstract][Full Text] [Related]
44. Parthenogenetic activation of mouse eggs by microinjection of a truncated c-kit tyrosine kinase present in spermatozoa.
Sette C; Bevilacqua A; Bianchini A; Mangia F; Geremia R; Rossi P
Development; 1997 Jun; 124(11):2267-74. PubMed ID: 9187152
[TBL] [Abstract][Full Text] [Related]
45. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development.
Agosti V; Corbacioglu S; Ehlers I; Waskow C; Sommer G; Berrozpe G; Kissel H; Tucker CM; Manova K; Moore MA; Rodewald HR; Besmer P
J Exp Med; 2004 Mar; 199(6):867-78. PubMed ID: 15024050
[TBL] [Abstract][Full Text] [Related]
46. PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia.
Brobeil A; Bobrich M; Graf M; Kruchten A; Blau W; Rummel M; Oeschger S; Steger K; Wimmer M
Leuk Res; 2011 Oct; 35(10):1367-75. PubMed ID: 21513978
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
Yang B; Wu J; Maddodi N; Ma Y; Setaluri V; Longley BJ
J Invest Dermatol; 2007 Sep; 127(9):2123-8. PubMed ID: 17495964
[TBL] [Abstract][Full Text] [Related]
48. A novel c-kit transcript, potentially encoding a truncated receptor, originates within a kit gene intron in mouse spermatids.
Rossi P; Marziali G; Albanesi C; Charlesworth A; Geremia R; Sorrentino V
Dev Biol; 1992 Jul; 152(1):203-7. PubMed ID: 1378413
[TBL] [Abstract][Full Text] [Related]
49. Local aromatase expression in human prostate is altered in malignancy.
Ellem SJ; Schmitt JF; Pedersen JS; Frydenberg M; Risbridger GP
J Clin Endocrinol Metab; 2004 May; 89(5):2434-41. PubMed ID: 15126575
[TBL] [Abstract][Full Text] [Related]
50. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
El Haibi CP; Sharma PK; Singh R; Johnson PR; Suttles J; Singh S; Lillard JW
Mol Cancer; 2010 Apr; 9():85. PubMed ID: 20412587
[TBL] [Abstract][Full Text] [Related]
51. NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells.
Das S; Hahn Y; Nagata S; Willingham MC; Bera TK; Lee B; Pastan I
Cancer Res; 2007 Feb; 67(4):1594-601. PubMed ID: 17308099
[TBL] [Abstract][Full Text] [Related]
52. Proteomics analysis of in vitro protein methylation during Src-induced transformation.
Chiou YY; Fu SL; Lin WJ; Lin CH
Electrophoresis; 2012 Feb; 33(3):451-61. PubMed ID: 22228245
[TBL] [Abstract][Full Text] [Related]
53. Src kinase induces tumor formation in the c-SRC C57BL/6 mouse.
Kline CL; Jackson R; Engelman R; Pledger WJ; Yeatman TJ; Irby RB
Int J Cancer; 2008 Jun; 122(12):2665-73. PubMed ID: 18351644
[TBL] [Abstract][Full Text] [Related]
54. Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.
Lee YC; Perren JR; Douglas EL; Raynor MP; Bartley MA; Bardy PG; Stephenson SA
BMC Cancer; 2005 Sep; 5():119. PubMed ID: 16171530
[TBL] [Abstract][Full Text] [Related]
55. Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.
Khoubehi B; Kessling AM; Adshead JM; Smith GL; Smith RD; Ogden CW
J Urol; 2001 Jun; 165(6 Pt 1):2115-20. PubMed ID: 11371938
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: might c-kit represent a therapeutic target?
Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Comazzi S; Dacasto M
Vet Immunol Immunopathol; 2013 Aug; 154(3-4):153-9. PubMed ID: 23791075
[TBL] [Abstract][Full Text] [Related]
57. Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation.
Janostiak R; Vyas M; Cicek AF; Wajapeyee N; Harigopal M
Exp Mol Pathol; 2018 Aug; 105(1):41-49. PubMed ID: 29852185
[TBL] [Abstract][Full Text] [Related]
58. Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis.
Tonary AM; Macdonald EA; Faught W; Senterman MK; Vanderhyden BC
Int J Cancer; 2000 May; 89(3):242-50. PubMed ID: 10861500
[TBL] [Abstract][Full Text] [Related]
59. Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity.
Arcuri F; Papa S; Carducci A; Romagnoli R; Liberatori S; Riparbelli MG; Sanchez JC; Tosi P; del Vecchio MT
Prostate; 2004 Jul; 60(2):130-40. PubMed ID: 15162379
[TBL] [Abstract][Full Text] [Related]
60. Dietary palmitate cooperates with Src kinase to promote prostate tumor progression.
Kim S; Yang X; Yin A; Zha J; Beharry Z; Bai A; Bielawska A; Bartlett MG; Yin H; Cai H
Prostate; 2019 Jun; 79(8):896-908. PubMed ID: 30900312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
